Heart failure Flashcards
Briefly describe the definition of HF
Of note - after a confirmed diagnosis, HF is categorised into HFreF vs. HFpeF (based on 2018 guidelines)
In addition to symptoms + signs of HF and an EF>50%, HFpEF requires additional objective parametres to favour in the diagnosis. What are the two categories of this?
Objective evidence of
1. Relevant structural heart disease
2. Evidence of diastolic dysfunction
Describe one finding that would be suggestive of stuctural heart disease
- LV hypertrophy
- left atrial enlargement
What are 2 features that may suggest diastolic dysfunction?
Some sort of raised filling pressure
- elevated BNP or NT proBNP
- evidence on exercise (invasive or stress TTE)
- evidence on TTE*
- findings on a cardiac cath
What is HF with improved EF?
- note these patients have a better prognosis
The diagnosis of HF (as per strong recommendation) includes an ECG (looking for LVH/ischaemia), CXR, BNP and TTE. Which of these shows high quality of evidence?
BNP
What value of BNP rules out a likely HF diagnosis?
<100
What value of NT proBNP rules out a HF diagnosis?
<300
What value of BNP rules in a Dx of HF?
BNP>400
What value of NT pro-BNP rules in a Dx of HF?
note this is age dependent
Once HF appears to be a likely diagnosis, there is often Ix into the cause. One possible cause is CAD. Outline how you would approach this
- consider angiogram for patients that are high risk (e.g. refractory angina, ventricular arrhythmiyas, intermediate - high probability of CAD)
- for low-moderate risk can consider non-invasive Ix such as CTCA or cardiac MRI
- if patients have ESTABLISHED CAD + HF, can consider SPECT, stress TTE, PET and CMR to assess the need for coronary vascularisation
A patient has a diagnosis of HF. What would be the next most useful Ix if it was found the patient has increased LV wall thickness on their TTE?
- Cardiac MRI - would assist to identify inflammatory and infiltrative cardiomyopathies
- PET + bone scintigraphy > the latter especially useful in amyloidosis
What is the mainstay treatment in decompensated CCF
- loop diuretics
- IV vasodilators if SBP>90
- IV ionotropes if peripheral hypopersfusion and SBP<90, and treatment towards easing congestion has failed (contraindicated if no evidence of peripheral hypoperfusion)
Where do loop diuretics work (e.g. furoseimide)?
thick ascending limb of the loop of Henle
Briefly outline the channel that enables Na reabsorption
- via transporting cells containing Na-K-ATPase pumps
> allows Na to return to the systemic circulation
> allows maintainence of Na concentration at low levels
> raise K above its electrochemical equilibrium, thus enabling polarisation of the inside of the cell
*Note sodium cannot move freely across a channel, it requires a tranposrter or channel
Which part of the nephron reabsorbs most of the sodium?
proximal tubule (approx 60-65%)
Outside of the proximal tubule, where else is Na reabsorbed?
loop of Henle (approx 20%)
Acetazolamide (a carbonic anhydrase inhibitor) acts at the proximal tubule. Why isn’t this an effective diuretic?
- Most of the filtered sodium is reabsorbed in the proximal tubule (approximately 60 to 65 percent) and the loop of Henle (20 percent).
- As a result, it might be expected that a proximally acting diuretic, such as the carbonic anhydrase inhibitor acetazolamide, could induce relatively large losses of sodium and water.
- However, this does not occur, since almost all of the excess fluid delivered out of the proximal tubule can be reabsorbed more distally, particularly in the loop of Henle and to a lesser degree the distal tubule
*sometimes distal reabsorption could also occur with a loop diuretic
List one other medication other than frusemide that is a loop diureitc
- bumetanide
- torsemide*
- ethacrynic acid*